New shot aims to ease stubborn back pain
NCT ID NCT07520240
First seen Apr 26, 2026 · Last updated May 07, 2026 · Updated 4 times
Summary
This early-stage study tests a new drug called ITX24-01 for people with severe chronic neck or lower back pain caused by facet joints. About 32 adults will receive either the drug or a placebo injection to check if it is safe and tolerable. The goal is to see if this approach can reduce pain with minimal side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FACET JOINT PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sydney Pain Management Centre
Wahroonga, New South Wales, 2076, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.